Current clinical consensus reflects the following: Research findings are preliminary and insufficient to guide treatment decisions No regulatory approval exists for using GLP-1s in addiction treatment Early signals do not outweigh the lack of long-term outcome data Instead, clinicians continue to recommend established, evidence-based approaches, including: Behavioral therapies tailored to substance use disorders Medication-assisted treatment when medically indicated Comprehensive psychosocial support and relapse-prevention planning Comprehensive assessment remains a cornerstone of safe and effective care
The plan is to offer patients a long-term extension period for their trials, giving whoever receives the placebo a chance to then switch and take the experimental drug
Some demand documentation of failed prior weight loss attempts, including supervised diet programs or other medications like phentermine , before approving GLP-1 coverage regardless of BMI
The gut anaerobe faecalibacterium prausnitzii uses an extracellular electron shuttle to grow at oxic-anoxic interphases
What Can GLP-1 Testing Reveal
And with that reminder, I choke down the handfuls of blueberries
